Diseases, Conditions, Syndromes

Study links severe COVID-19 to increase in self-attacking antibodies

Hospitalized COVID-19 patients are substantially more likely to harbor autoantibodies—antibodies directed at their own tissues or at substances their immune cells secrete into the blood—than people without COVID-19, according ...

Diseases, Conditions, Syndromes

A COVID-19 vaccine strategy to give the body 'border protection'

A simple addition to injected COVID-19 vaccines could enhance their effectiveness and provide "border protection" immunity in areas like the nose and mouth to supplement antibodies in the bloodstream, new research suggests.

Diseases, Conditions, Syndromes

New study provides data on protections of Ebola vaccines

A new study published in Science Translational Medicine reports on the Ebola vaccine-mediated protection of five mucosal vaccine vectors based on the human and avian paramyxoviruses. The study comprehensively characterized ...

Diseases, Conditions, Syndromes

The long view on COVID-19 vaccine safety and efficacy

The mRNA vaccines for COVID-19, made by Pfizer/BioNTech and Moderna, are among the most powerful vaccines the world has ever seen. According to clinical trial data, they are more than 94% effective at preventing symptomatic ...

page 7 from 40